Regencell Bioscience Holdings L

17.28+0.77 (+4.66%)

Oct 28, 4:00:00 PM EDT · NasdaqCM · RGC · USD

Upcoming Earnings

Report date

≈ Nov 3, 2025 (in 5 days)

Key Stats

Market Cap

8.54B

P/E (TTM)

Basic EPS (TTM)

-0.01

Dividend Yield

About

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

CEO

Mr. Yat-Gai Au

IPO

7/16/2021

Website

https://www.regencellbioscience.com

Employees

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic